Human Medicines (Amendments Relating to Naloxone and Transfers of Functions) Regulations 2024 Work package

A work package focussed on the Human Medicines (Amendments Relating to Naloxone and Transfers of Functions) Regulations 2024, made available on 29 July 2024, subject to the Draft affirmative procedure.

There are 16 business items actualising 20 steps.

RSS

Business items having happened

29 July 2024
3 September 2024
1. Considered by the Secondary Legislation Scrutiny Committee (SLSC) (House of Lords)
  Concerns raised by the Secondary Legislation Scrutiny Committee (SLSC) (House of Lords)
4 September 2024
1. Further information published by the Secondary Legislation Scrutiny Committee (SLSC) (House of Lords)
9 September 2024
1. Chamber debate (House of Commons)
2. Question on motion to approve the instrument put (House of Commons)
  Instrument approved (House of Commons)
16 October 2024
1. Considered by the Joint Committee on Statutory Instruments (JCSI) (House of Commons and House of Lords)
  Instrument not drawn to the special attention of the Houses by the Joint Committee on Statutory Instruments (JCSI) (House of Commons and House of Lords)
17 October 2024
1. Motion to approve the instrument tabled by the Government (House of Lords)
22 October 2024
1. Grand Committee debate (House of Lords)
23 October 2024
4 November 2024
1. Instrument made (signed into law)
2 December 2024
1. Instrument comes into force as law

Work package identifier

https://id.parliament.uk/MyJckbp6

SPARQL queries used by this page

PREFIX rdfs: <http://www.w3.org/2000/01/rdf-schema#>
      PREFIX : <https://id.parliament.uk/schema/>
      PREFIX id: <https://id.parliament.uk/>
      SELECT * where {
  
       ?Paper a :WorkPackagedThing .  
           ?Paper :name ?Papername ;
           :workPackagedThingHasWorkPackage ?workPackage.
        filter (?workPackage IN (id:MyJckbp6))
           ?workPackage :workPackageHasBusinessItem ?businessItem. 
           ?workPackage :workPackageHasProcedure ?procedure.
         optional {?businessItem :businessItemDate ?businessItemDate}
        optional {?businessItem :businessItemHasBusinessItemWebLink ?businessItemLink}
       ?businessItem :businessItemHasProcedureStep ?businessItemProcedureStep. 
       ?businessItemProcedureStep :name ?businessItemProcedureStepName.
       ?businessItemProcedureStep :procedureStepHasStepDisplayDepthInProcedure ?stepDepth.
        ?procedure :procedureHasStepDisplayDepthInProcedure ?stepDepth.
       ?stepDepth :stepDisplayDepthInProcedureHasDepth ?depthValue.
        Optional {?businessItemProcedureStep :procedureStepInLegislature ?legislature.
          ?legislature :name ?legislatureName.}
        Optional {?businessItemProcedureStep :procedureStepHasHouse ?CommonsId.
              filter (?CommonsId IN (id:1AFu55Hs))}
        Optional {?businessItemProcedureStep :procedureStepHasHouse ?LordsId.
          filter (?LordsId IN (id:WkUWUBMx))} }  order by ?businessItemDate ?depthValue ?businessItem

Human Medicines (Amendments Relating to Naloxone and Transfers of Functions) Regulations 2024 Work package

Business items having happened

29 July 2024

3 September 2024

4 September 2024

9 September 2024

16 October 2024

17 October 2024

22 October 2024

23 October 2024

4 November 2024

2 December 2024

Work package identifier